| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/09/2001 | US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome |
| 10/09/2001 | US6299898 Methods and compositions for the treatment of wounds |
| 10/09/2001 | US6299882 UL54.5 of Marek's disease virus (MDV) |
| 10/09/2001 | US6299650 Method for in vitro production of bone |
| 10/09/2001 | CA1341303C Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (adcc) treatment of cancer and other diseases |
| 10/09/2001 | CA1341301C Preparation of functional human urokinase proteins |
| 10/04/2001 | WO2001073094A2 Novel sperm-dna complexes for genetically modifying non-human animals |
| 10/04/2001 | WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 10/04/2001 | WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 10/04/2001 | WO2001072970A2 Methods to prepare and use epidermal stem cells |
| 10/04/2001 | WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | WO2001072782A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 10/04/2001 | WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer |
| 10/04/2001 | WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists |
| 10/04/2001 | WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | WO2001072279A2 Medical emulsion for lubrication and delivery of drugs |
| 10/04/2001 | WO2001072277A2 Immunotherapeutic methods and compositions |
| 10/04/2001 | WO2001072120A2 A strategy for maintaining pregnancy |
| 10/04/2001 | WO2001043704A8 A skin care composition that mediates cell to cell communication |
| 10/04/2001 | WO2001032685A3 Gene expression directed by a super-psa promoter |
| 10/04/2001 | WO2001032129A3 Augmentation and repair of age-related soft tissue defects |
| 10/04/2001 | WO2001022990A3 Methods related to immunostimulatory nucleic acid-induced interferon |
| 10/04/2001 | WO2001013956A3 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 10/04/2001 | WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 10/04/2001 | WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 10/04/2001 | WO2000046355A9 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 10/04/2001 | WO2000043039A9 Vaccine-mediated treatment of neurological disorders |
| 10/04/2001 | US20010026937 Culturing population of peripheral blood or bone marrow mononuclear cells in interleukin-4, granulocyte macrophage colony stimulating factor, and culture medium comprising insulin, transferrin, linoleic acid, oleic acid, palmitic acid |
| 10/04/2001 | US20010026795 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 10/04/2001 | US20010026794 Two heterologous DNA encoding gene products; prolonged half-life |
| 10/04/2001 | EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement |
| 10/04/2001 | EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
| 10/04/2001 | EP1137766A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 10/04/2001 | EP1137764A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 10/04/2001 | EP1137762A1 Treatment of pompe's disease |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP1137434A2 New cancer treatments |
| 10/04/2001 | EP1137430A2 Therapeutic agent for the suppression of snoring noises |
| 10/04/2001 | EP1137424A1 Preparation which contains oligosaccharides and probiotics |
| 10/04/2001 | EP1137423A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 10/04/2001 | EP1137422A2 Use of human prostate cell lines in cancer treatment |
| 10/04/2001 | EP1137421A1 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation |
| 10/04/2001 | EP0918464B1 Process for production of colostral milk products and use thereof |
| 10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 10/04/2001 | EP0784693B1 Viral vectors for gene therapy |
| 10/04/2001 | EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 10/04/2001 | CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | CA2404085A1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | CA2402780A1 Insulin and igf-1 receptor agonists and antagonists |
| 10/04/2001 | CA2401638A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 10/03/2001 | CN1316023A Method and apparatus for copper plating using electroless plating and electroplating |
| 10/03/2001 | CN1315859A Substances having antiobese and visceral fat-reducing functions and utilization thereof |
| 10/03/2001 | CN1315202A Ointment for treating psoriasis |
| 10/03/2001 | CN1315201A Ointment for treating acne |
| 10/03/2001 | CN1315197A Medicine for female acyesis |
| 10/03/2001 | CN1315195A Jingan shierkang capsule and its preparing process |
| 10/03/2001 | CN1315194A Capsule for invigorating function of brain and its preparing process |
| 10/03/2001 | CN1315181A Electrode method for extracting toxic liquid from living scorpion |
| 10/03/2001 | CN1315180A Male silkmoth capsule and its preparing process |
| 10/03/2001 | CN1315147A Instant flour for taking care of breast and its preparing process |
| 10/03/2001 | CN1072018C Compound traditional Chinese medicine for giving-up drug-taking and its compounding method |
| 10/03/2001 | CN1072015C Medicine for treating hydrocephalus |
| 10/02/2001 | US6297364 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 10/02/2001 | US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter |
| 10/02/2001 | US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed. |
| 10/02/2001 | US6297050 Activation of t-cell response; mix peptides with sample containing t-cells and detect bound human leukocyte antigens |
| 10/02/2001 | US6297043 Molecular formula of c28 h20 o12; culture product from streptomyces which inhibits glucose-6-phosphate translocase; antidiabetic agents |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 10/02/2001 | US6297004 Retroviral particles that infect eukaryotic cells; for somatic gene therapy; for use as diagnostic tool in viral detection; viricides |
| 10/02/2001 | US6296879 Ruminal fluid inoculation of calves |
| 10/02/2001 | US6296878 Anti-inflammatory and anti-itching action, prevention and/or treatment of disorders of cardiovascular system, protective action against ultraviolet radiation, analgesic, promotive action on proliferation of fibroblasts, therapy of fire burn |
| 10/02/2001 | US6296846 Induced tolerance to xenografts |
| 10/02/2001 | US6296845 Contacting under infective conditions, a recombinant replication deficient adenovirus lacking an expressed viral oncoprotein capable of binding functional p53 tumor suppressor gene product, with neoplastic cellsnon-neoplastic cells |
| 09/27/2001 | WO2001071017A2 Modified nodavirus rna for gene delivery |
| 09/27/2001 | WO2001071016A1 Pluripotential stem cells |
| 09/27/2001 | WO2001071007A2 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | WO2001070950A2 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 09/27/2001 | WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein |
| 09/27/2001 | WO2001070767A2 Therapeutic anti-melanoma compounds |
| 09/27/2001 | WO2001070267A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 09/27/2001 | WO2001070261A1 Sperm factor oscillogenin |
| 09/27/2001 | WO2001070246A1 Use of lactic acid bacterium for the treatment of peritonitis |
| 09/27/2001 | WO2001070243A2 A method for treating early breast cancer |
| 09/27/2001 | WO2001070199A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 09/27/2001 | WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy |